what are glp-1 drugs for weight loss Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response Study finds GLP-1 receptor agonists

And they point the way to a new class of antidepressants that could be freer of side effects and faster-acting than those in use today, and that may help patients for whom existing treatments don't work or have stopped working

placebo in the fall of eGFR was better among patients with macroalbuminuria or in those with eGFR between 3060 ml/min/1.73 m2,100 and in the AWARD-7 trial the effect of dulaglutide on renal clinical outcomes and eGFR decline was more pronounced in participants with macroalbuminuria at baseline.66 Likewise, in a post hoc analysis of the LEADER study those patients who experienced a 30% reduction in albuminuria during follow-up had fewer cardiovascular and renal events,101 which confirms that a reduction in albuminuria is associated with a reduction in cardiovascular and renal events.99,102 Finally, the renal benefits of arGLP-1 appear to be additive to those of iSGLT2, which is of particular interest in patients with DKD.85,86,103 Cardiovascular and renal benefits of these drugs have been also demonstrated in real-life studies.104105 The causes of renal protection by some arGLP-1 s are unclear

Considering peptides

Additionally, meta-analyses have shown that increased ALDH1 expression in ovarian cancer is associated with poor prognosis, shorter progression-free survival, and unfavorable clinical features (53)

DM is characterized by elevated blood sugar (glycemic) levels, therefore the role of these drugs is to reduce glycemic levels, possibly avoiding hypoglycemic events